Dennis & Brett Sims

Father/son running the Toledo Glass City Half Marathon
  • My Goal:
  • $3,500
  • Raised So Far:
  • $3,000
  • # of Donations:
  • 28
$3000 of $3500 goal
+
Select a media type above to begin uploading photos and videos

Welcome to our fundraising page!

Father and son will be running the Glass City Half Marathon in Toledo, OH on April 23, 2017.  Brett completed his first half marathon in September 2016.  This will be Dennis' first ever half marathon, at age 62!  We are running to raise awareness and funds for Choroideremia research to help find a treatment and cure for blindness caused by Choroideremia.

Brett is affected by Choroideremia and currently has only about 20 degrees of vision left in each eye.  He was the 2nd patient to be treated in the first ever gene therapy clinical trial in the United States at Penn University in March of 2015.  Since then, several other clinical trials have begun throughout the United States.  We are so close!  Any donation of any amount will help greatly!  If you're unable to donate, please consider sharing our page.

Help us support the Choroideremia Research Foundation by making a donation. The process is fast, easy, and secure. We truly appreciate any support you can provide. Each donation will help us to save sight and end blindness caused by Choroideremia (CHM).  Researchers are close to a curing CHM, but are still in need of critical research funds to finish their work and your donation will help us get there!

Thanks so much for your generosity!

R Share
x Hide
My Story
The Cause
Dennis Sims is fundraising for Team CHM benefiting Choroideremia Research Foundation.

Welcome to our fundraising page!

Father and son will be running the Glass City Half Marathon in Toledo, OH on April 23, 2017.  Brett completed his first half marathon in September 2016.  This will be Dennis' first ever half marathon, at age 62!  We are running to raise awareness and funds for Choroideremia research to help find a treatment and cure for blindness caused by Choroideremia.

Brett is affected by Choroideremia and currently has only about 20 degrees of vision left in each eye.  He was the 2nd patient to be treated in the first ever gene therapy clinical trial in the United States at Penn University in March of 2015.  Since then, several other clinical trials have begun throughout the United States.  We are so close!  Any donation of any amount will help greatly!  If you're unable to donate, please consider sharing our page.

Help us support the Choroideremia Research Foundation by making a donation. The process is fast, easy, and secure. We truly appreciate any support you can provide. Each donation will help us to save sight and end blindness caused by Choroideremia (CHM).  Researchers are close to a curing CHM, but are still in need of critical research funds to finish their work and your donation will help us get there!

Thanks so much for your generosity!

Continue Reading

See more activity ...
Donate Log In
About

The Campaign:

Team CHM

Team CHM is a group of athletes committed to Ending Blindness caused by Choroideremia (CHM).   We r

The Organization:

Choroideremia Research Foundation

The Choroideremia Research Foundation Inc. is an international, non-profit organization dedicated to...

Fundraisers